Fundz

Xellar Biosystems secures tens of millions of yuan in strategic financing to expand its AI-driven 3D Bio Intelligence platform for drug research.

PRIVATENov 19, 2026

Round Type

Venture

BiotechnologyArtificial Intelligence

Investors

CSPC Pharmaceutical Group (pharmaceutical investment fund)Shanghai State-backed investment company

Description

Xellar Biosystems has secured tens of millions of yuan in strategic financing to advance its artificial intelligence platform designed to improve early-stage drug testing. The investors include a Shanghai State-backed investment company and a pharmaceutical investment fund linked to Chinese drugmaker CSPC Pharmaceutical Group. The funding will support the company's 3D Bio Intelligence platform, which combines organ-on-a-chip technology, three-dimensional cell imaging, and automated experiments with AI analysis. The capital will help scale up the platform and strengthen its AI capabilities.

Quick answer

Xellar Biosystems raised an undisclosed amount in a funding round, dated November 19, 2026. Investors: CSPC Pharmaceutical Group (pharmaceutical investment fund) and Shanghai State-backed investment company.

How much did Xellar Biosystems raise?
Xellar Biosystems raised an undisclosed amount in a funding round on November 19, 2026.
Who invested in Xellar Biosystems?
CSPC Pharmaceutical Group (pharmaceutical investment fund) and Shanghai State-backed investment company are named as investors in this round.
What does Xellar Biosystems do?
Xellar Biosystems is a globally leading innovator specializing in next-generation artificial intelligence and computer vision-assisted drug discovery.
Where is Xellar Biosystems based and how big is it?
Fundz records about 27 employees.
Who are the decision-makers at Xellar Biosystems?
Fundz holds 1 contact at Xellar Biosystems, including the Senior Director of Business Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as Xellar Biosystems that raised within 45 days of this round, from Fundz verified event records.

  • Tesorai raised $5.3M (Seed) on November 18, 2026.
  • ChronoScale Holdings Corp raised $153M (Series C) on November 18, 2026.
  • Soombit AI raised $9M (Series A) on November 17, 2026.
  • MedInTech raised $25M (Series C) on November 16, 2026.
  • TestDynamics raised $9M (Series A) on November 16, 2026.
  • Boston Medical Sciences raised $35M (Series B) on November 13, 2026.

Who to call at Xellar Biosystems, and when

A new round usually means Xellar Biosystems is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xellar Biosystems raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xellar Biosystems, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xellar Biosystems. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xellar Biosystems

About

Xellar Biosystems is a globally leading innovator specializing in next-generation artificial intelligence and computer vision-assisted drug discovery. The company focuses on developing organ-on-a-chip-based platforms for drug discovery and development. Xellar aims to advance the integration of technology in the life sciences field.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xellar Biosystems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJeff B., Senior Director of Business Development hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Xellar Biosystems's next move

See what Strategic adds

Xellar Biosystems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.